A Phase 1 Study to Evaluate the Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects
Latest Information Update: 11 Oct 2021
At a glance
- Drugs Cefepime/taniborbactam (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors VenatoRx Pharmaceuticals
- 30 Sep 2021 Status changed from recruiting to completed.
- 12 Jul 2021 New trial record